Evidence map›Paper›PMID 26102360›Full record

ArticlePloS one2015

Effects of a Balanced Translocation between Chromosomes 1 and 11 Disrupting the DISC1 Locus on White Matter Integrity.

Heather C Whalley, Rali Dimitrova, Emma Sprooten, Maria R Dauvermann, Liana Romaniuk, Barbara Duff, Andrew R Watson, Bill Moorhead, Mark Bastin, Scott I Semple and 11 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Using mouse transgenic and human stem cell technologies to model genetic mutations associated with schizophrenia and autism.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2018
    Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 10 institutions in 2 countries.

Heather C WhalleyDivision of Psychiatry, University of Edinburgh, Edinburgh, United Kingdom.
Rali DimitrovaDivision of Psychiatry, University of Edinburgh, Edinburgh, United Kingdom; Centre for the Developing Brain, St Thomas' Hospital, King's College London, London, United Kingdom.
Emma SprootenDepartment of Psychiatry, Yale University, New Haven, CT, United States of America.
Maria R DauvermannDivision of Psychiatry, University of Edinburgh, Edinburgh, United Kingdom; McGovern Institute for Brain Research, Cambridge, MA, United States of America.
Liana RomaniukDivision of Psychiatry, University of Edinburgh, Edinburgh, United Kingdom.
Barbara DuffDivision of Psychiatry, University of Edinburgh, Edinburgh, United Kingdom.
Andrew R WatsonDivision of Psychiatry, University of Edinburgh, Edinburgh, United Kingdom.
Bill MoorheadDivision of Psychiatry, University of Edinburgh, Edinburgh, United Kingdom.
Mark BastinCentre for Clinical Brain Sciences, Western General Hospital, University of Edinburgh, Edinburgh, United Kingdom.
Scott I SempleClinical Research Imaging Centre, University of Edinburgh, Edinburgh, United Kingdom; British Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom.
Stephen GilesDivision of Psychiatry, University of Edinburgh, Edinburgh, United Kingdom.
Jeremy HallDivision of Psychiatry, University of Edinburgh, Edinburgh, United Kingdom; Neuroscience and Mental Health Research Institute, Cardiff University, Cardiff, United Kingdom.
Pippa ThomsonDepartment of Medical Genetics, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom.
Neil RobertsClinical Research Imaging Centre, University of Edinburgh, Edinburgh, United Kingdom; Centre for Inflammation Research, University of Edinburgh, Edinburgh, United Kingdom.
Zoe A HughesNeuroscience Research Unit, Pfizer Inc, Cambridge, MA, United States of America.
Nick J BrandonNeuroscience Research Unit, Pfizer Inc, Cambridge, MA, United States of America; Current affiliation: AstraZeneca Neuroscience IMED, Cambridge, MA, United States of America.
John DunlopNeuroscience Research Unit, Pfizer Inc, Cambridge, MA, United States of America; Current affiliation: AstraZeneca Neuroscience IMED, Cambridge, MA, United States of America.
Brandon WhitcherClinical and Translational Imaging, Pfizer Inc, Cambridge, MA, United States of America.
Douglas H R BlackwoodDivision of Psychiatry, University of Edinburgh, Edinburgh, United Kingdom.
Andrew M McIntoshDivision of Psychiatry, University of Edinburgh, Edinburgh, United Kingdom.
Stephen M LawrieDivision of Psychiatry, University of Edinburgh, Edinburgh, United Kingdom.
University of Edinburgh · GBAstraZeneca (United States) · USPfizer (United States) · USCardiff University · GBCentre for Inflammation Research · GBKing's College London · GBMcGovern Institute for Brain Research · USMRC Institute of Genetics and Molecular Medicine · GBWestern General Hospital · GBYale University · US

Funding

Medical Research Council G0600429Medical Research Council MR/J004367/1Medical Research Council MR/K026992/1Medical Research Council MR/L010305/1Wellcome Trust 104036
6 · The paper itself

Abstract

objectiveIndividuals carrying rare, but biologically informative genetic variants provide a unique opportunity to model major mental illness and inform understanding of disease mechanisms. The rarity of such variations means that their study involves small group numbers, however they are amongst the strongest known genetic risk factors for major mental illness and are likely to have large neural effects. DISC1 (Disrupted in Schizophrenia 1) is a gene containing one such risk variant, identified in a single Scottish family through its disruption by a balanced translocation of chromosomes 1 and 11; t(1;11) (q42.1;q14.3).

methodWithin the original pedigree, we examined the effects of the t(1;11) translocation on white matter integrity, measured by fractional anisotropy (FA). This included family members with (n = 7) and without (n = 13) the translocation, along with a clinical control sample of patients with psychosis (n = 34), and a group of healthy controls (n = 33).

resultsWe report decreased white matter integrity in five clusters in the genu of the corpus callosum, the right inferior fronto-occipital fasciculus, acoustic radiation and fornix. Analysis of the mixed psychosis group also demonstrated decreased white matter integrity in the above regions. FA values within the corpus callosum correlated significantly with positive psychotic symptom severity.

conclusionsWe demonstrate that the t(1;11) translocation is associated with reduced white matter integrity in frontal commissural and association fibre tracts. These findings overlap with those shown in affected patients with psychosis and in DISC1 animal models and highlight the value of rare but biologically informative mutations in modeling psychosis.

Indexed as

Diffusion Tensor ImagingTranslocation, GeneticAdolescentAdultBipolar DisorderChromosomes, Human, Pair 1Chromosomes, Human, Pair 11Corpus CallosumCyclothymic DisorderExonsFemaleHumansMajor Depressive DisorderMaleMiddle AgedNerve Tissue ProteinsDISC1 protein, humanNerve Tissue Proteins

Identifiers

PMID26102360
PMCPMC4477898
OpenAlexW1845875257

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.